PA

Perceptive Advisors Portfolio holdings

AUM $2.67B
1-Year Return 73.17%
This Quarter Return
+59.23%
1 Year Return
+73.17%
3 Year Return
+837.18%
5 Year Return
+928.4%
10 Year Return
+11,818.46%
AUM
$1.54B
AUM Growth
+$309M
Cap. Flow
-$78.6M
Cap. Flow %
-5.11%
Top 10 Hldgs %
50.34%
Holding
230
New
58
Increased
26
Reduced
57
Closed
33

Sector Composition

1 Healthcare 92.13%
2 Technology 0.1%
3 Consumer Discretionary 0.08%
4 Industrials 0.07%
5 Consumer Staples 0.04%
Name Market Value Portfolio Weight Shares or Principal Shares
Change %
Capital Flow
AVGR
176
DELISTED
Avinger, Inc. Common Stock
AVGR
0
-$13K
SLRX icon
177
Salarius Pharmaceuticals
SLRX
$2.4M
0
-$2K
EGRX
178
DELISTED
Eagle Pharmaceuticals, Inc.
EGRX
$3K ﹤0.01%
544,770
+244,770
+82% +$1.35K
AORT icon
179
Artivion
AORT
$2.05B
$2K ﹤0.01%
+123
New +$2K
MD icon
180
Pediatrix Medical
MD
$1.49B
$2K ﹤0.01%
+29
New +$2K
SGMO icon
181
Sangamo Therapeutics
SGMO
$165M
$1K ﹤0.01%
+272
New +$1K
TNGN
182
DELISTED
TENGION INC COM NEW STK (DE)
TNGN
$1K ﹤0.01%
1,826,399
ABBV icon
183
AbbVie
ABBV
$375B
-1,250
Closed -$77K
ARCT icon
184
Arcturus Therapeutics
ARCT
$485M
-146,896
Closed -$4.62M
ATRA icon
185
Atara Biotherapeutics
ATRA
$90.7M
-100
Closed -$56K
BCLI
186
DELISTED
BRAINSTORM CELL THERAPUTC
BCLI
-26,667
Closed -$964K
CLDX icon
187
Celldex Therapeutics
CLDX
$1.52B
-4,742
Closed -$312K
CNC icon
188
Centene
CNC
$14.2B
-9,896
Closed -$353K
CORT icon
189
Corcept Therapeutics
CORT
$7.31B
-11,000
Closed -$60K
CTMX icon
190
CytomX Therapeutics
CTMX
$376M
-742,021
Closed -$7.58M
DVAX icon
191
Dynavax Technologies
DVAX
$1.18B
-2,499
Closed -$36K
ELDN icon
192
Eledon Pharmaceuticals
ELDN
$162M
-4,081
Closed -$3.64M
GMED icon
193
Globus Medical
GMED
$8.18B
-50,000
Closed -$1.19M
HEDJ icon
194
WisdomTree Europe Hedged Equity Fund
HEDJ
$1.79B
0
HLF icon
195
Herbalife
HLF
$1.02B
-2,500
Closed -$73K
HUM icon
196
Humana
HUM
$37B
0
IONS icon
197
Ionis Pharmaceuticals
IONS
$9.76B
0
LCTX icon
198
Lineage Cell Therapeutics
LCTX
$279M
-15,705
Closed -$36K
LLY icon
199
Eli Lilly
LLY
$652B
0
LPCN icon
200
Lipocine
LPCN
$15.7M
0